News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Dr Nick Zdenkowski is a clinician-researcher with an interest in breast cancer. He would like…
The Royal Australian and New Zealand College of Radiologists (RANZCR) is pleased to announce that…
Chimeric antigen receptor (CAR) T cell therapy is a form of immunotherapy in which T…
Chemoimmunotherapy (CIT) is still standard treatment for patients with chronic lymphocytic leukaemia (CLL), particularly when…
Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults, and approximately 25%…
Acute myeloid leukaemia (AML) predominantly occurs in older adults over 65 years, who exhibit a…
Mantle cell lymphoma (MCL) is an aggressive type of non-Hodgkin lymphoma that develops from B…
Mutations in SF3B1 and U2AF1 can drive overexpression of activated IRAK4 — which regulates inflammation and promotes cancer cell…
High-risk patients with TP53-mutated acute myeloid leukaemia (AML) have limited treatment options and very poor prognoses.…
Chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab (FCR) is effective in treating patients with chronic lymphocytic leukaemia (CLL),…